Mitsubishi Tanabe Pharma Corporation
4508.TUnlisted companyMitsubishi Tanabe Pharma Corporation in brief
Mitsubishi Tanabe Pharma Corporation is an unlisted company in the Healthcare sector, based in Japan. It was founded in 2007. In the year to Mar 2019 it had sales of $3.8 B and a net profit of $337 M, about 9 cents of profit for every dollar of sales.
Written from the figures on this page, so it changes when they do. Dates and sources are under Sources and freshness.
About Mitsubishi Tanabe Pharma Corporation
Tanabe Pharma Corporation (田辺ファーマ株式会社, Tanabe Fāma Kabushiki-gaisha) is a Japanese pharmaceuticals company from Osaka, a subsidiary of Mitsubishi Chemical Holdings Corporation. Mitsubishi Pharma Corporation (三菱ウェルファーマ株式会社, Mitsubishi Werufāma Kabushiki-gaisha) was formed in 2001 from the merger of Mitsubishi-Tokyo Pharmaceuticals and Welfide Corporation. On October 1, 2007, Tanabe Seiyaku Co., Ltd. merged with Mitsubishi Pharma to form Mitsubishi Tanabe Pharma.
The company name until November 30, 2025 was Mitsubishi Tanabe Pharma Corporation (田辺三菱製薬株式会社, Tanabe Mitsubishi Seiyaku Kabushiki-gaisha).
Originally founded in 1678, Mitsubishi Tanabe considers itself as one of the oldest pharmaceutical companies in the world. Tanabe Pharma was a member of the Mitsubishi Chemical Group keiretsu.
From Wikipedia: read the full article · text available under CC BY-SA 4.0
Mitsubishi Tanabe Pharma Corporation timeline
- 1933
- 🏁Founded
- 1949
- 🔔· approximateInitial public offering on Tokyo Stock Exchange as 4508
- 2020
- 📉· approximateDelisted from Tokyo Stock Exchange
Events of Mitsubishi Tanabe Pharma Corporation from Wikidata. Dates marked approximate come from statements without a cited source. Spotted a mistake? Use the correction form below.
More about Mitsubishi Tanabe Pharma Corporation
- Acquisitions and changes
- MITSUBISHI TANABE PHARMA CORPORATION acquired by MITSUBISHI CHEMICAL
Market cap history
Not enough history yet.
Annual results
- Revenue
- $3.8 B
- Operating income
- —
- Net income
- $337 M
Mar-2019 ending year
Brands of Mitsubishi Tanabe Pharma Corporation (1)#
Brand
Source: Wikidata. Brands whose Wikidata item names Mitsubishi Tanabe Pharma Corporation (or a subsidiary of it) as owner, maker or parent organization; each brand's page links to its item
Where Mitsubishi Tanabe Pharma Corporation operates: 1 country#
Countries where the company has its headquarters, an office, subsidiaries, a branch or reported revenue.
Only the headquarters country is on file for Mitsubishi Tanabe Pharma Corporation: no subsidiaries, branches, offices or country revenue elsewhere in the GLEIF register, its SEC filings or Wikidata.
| Country | Presence | Revenue there |
|---|---|---|
| 🇯🇵 Japan | Headquarters1 office | — |
Source: GLEIF legal-entity register, SEC Exhibit 21 and annual reports, office addresses on file; map outlines from Natural Earth. A country without subsidiaries or offices on record is not listed even if the company sells there. How presence is decided
H-1B hiring at Mitsubishi Tanabe Pharma Corporation#
1 labor condition applications certified in fiscal 2026 for 1 positions, at a median wage of $220 K a year.
| Job title | Positions | Median wage offered |
|---|---|---|
| Business Development & Licensing Deal AssociateStatisticians | 1 | $220 K |
Where: Jersey City, NJ 1
| Fiscal year | Certified | Positions | Median wage | Filed |
|---|---|---|---|---|
| FY2026 | 1 | 1 | $220 K | 1 |
| FY2025 | 1 | 1 | $197 K | 1 |
Source: US Department of Labor, LCA disclosure data. An application is not a visa: USCIS decides each petition later, and the yearly lottery limits new H-1B visas. Filed as Mitsubishi Tanabe Pharma America, Inc.
How Mitsubishi Tanabe Pharma Corporation compares in Healthcare
- Revenue$3.8 B · higher than 90% of 1,795
- Net margin8.8% · higher than 67% of 1,485
- 🇿🇦 Mediclinic International$3.8 B
- 🇺🇸 AptarGroup, Inc.$7.6 B
- 🇨🇳 CSPC Pharmaceutical Group Limited$13.4 B
- 🇯🇵 Ship Healthcare Holdings, Inc.$1.4 B
- 🇩🇰 H. Lundbeck A/S$6.3 B
- 🇩🇰 Genmab A/S$21.0 B
Peer comparison · Healthcare
| Company | Market cap | P/E | Net margin | Rev. growth |
|---|---|---|---|---|
| Mitsubishi Tanabe Pharma Corporation🇯🇵 | $10.4 B | — | 8.8% | — |
| Eli Lilly and Company🇺🇸 | $1.20 T | 43.4× | 31.9% | +44.7% |
| Johnson & Johnson🇺🇸 | $652.5 B | 40.5× | 16.2% | +6.0% |
| AbbVie Inc.🇺🇸 | $514.0 B | 49.7× | 15.7% | +8.6% |
| Roche Holding AG🇨🇭 | $370.3 B | 29.1× | 19.0% | — |
| UnitedHealth Group Incorporated🇺🇸 | $367.7 B | 23.1× | 3.5% | +11.8% |
| Merck & Co., Inc.🇺🇸 | $359.8 B | 146.7× | 3.6% | +1.3% |
| Novartis AG🇨🇭 | $286.8 B | 20.5× | 24.7% | — |
| Thermo Fisher Scientific Inc.🇺🇸 | $253.8 B | 35.9× | 14.9% | +3.9% |
P/E and margins use trailing 12-month results where available; growth is the latest fiscal year.
Questions, comparisons and similar companies#
Compare head to head
Similar companies by size and industry
- Eli Lilly and Company$1.20 T
- Johnson & Johnson$652.5 B
- AbbVie Inc.$514.0 B
- Roche Holding AG$370.3 B
- UnitedHealth Group Incorporated$367.7 B
- Merck & Co., Inc.$359.8 B
Sources and freshness
- Market cap:
- Jan 1, 2020 (last known)
- Annual results:
- Mar-2019 ending year
- Balance sheet:
- Mar-2019 ending year
- Profile updated:
- Nov 19, 2026
Figures from value.today research, Wikipedia, Wikidata.
How each figure is collected: data sources and methodology. Market caps in US dollars unless you switch the currency.
Work at Mitsubishi Tanabe Pharma Corporation? Verify and update this profile — free
Show Mitsubishi Tanabe Pharma Corporation's ranking on your website Get the badge
The badge updates itself as the ranking changes.